Ryan T. Kelly is a professor in the Department of Chemistry and Biochemistry at Brigham Young University and co-founder of MicrOmics Technologies. He earned his Ph.D. in chemistry from BYU and subsequently spent more than a decade at Pacific Northwest National Laboratory. There, he served as Chief Technologist for the Environmental Molecular Sciences Laboratory and held leadership roles in instrument development, microfabrication, scientific computing and technology commercialization.
Dr. Kelly is a bioanalytical chemist whose research develops technologies that make mass spectrometry-based proteomics more sensitive, rapid, automated and accessible. His work spans microfluidic sample preparation, nanoelectrospray ionization, high-throughput liquid chromatography, mass spectrometry instrumentation and automated data processing. His research group pioneered the nanoPOTS platform for nanodroplet sample preparation and establish label-free single-cell proteomics, enabling thousands of proteins to be quantified from individual mammalian cells. His group has extended these capabilities to high-resolution spatial proteomics and developed automated sample-preparation workflows, multicolumn nanoLC platforms capable of analyzing hundreds of samples per day and open-source software for managing and processing large proteomics studies.
Dr. Kelly is an inventor on numerous issued and pending patents, several of which have been licensed or commercialized. His work has been recognized with two R&D 100 Awards, a Federal Laboratory Consortium Award for Excellence in Technology Transfer, the HTC Innovation Award and the Georges Guiochon Faculty Fellowship. He currently serves as President of the International Society for Single-Cell Mass Spectrometry, as a member of the US Human Proteome Organization Board of Directors and as a Topic Editor for the Journal of Proteome Research.